Klinika Oczna

Abstract

3/2021 vol. 123
Review paper

Phytocannabinoids and the eye – a systematic review

  1. Division of Ophthalmology with the Children’s Ophthalmology Subunit, Stefan Żeromski Specialist Hospital in Krakow, Poland
  2. Department of Retinal and Vitreous Surgery, Medical University of Lublin, Poland
KLINIKA OCZNA 2021, 123, 3: 114–121
Online publish date: 2021/10/13
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Recently, the use of marihuana for medical purposes has become more common. It can lead to many desired effects within the eye, as well as several adverse ones (i.a.: decrease in intraocular pressure, reduction of corneal pain and suppression of inflammation after chemical injury of cornea, treatment of blepharospasm, reduction of nystagmus, decrease in corneal endothelial cell density, eye irritation). There have not been enough studies with human subjects done on the safety and effectiveness of cannabis use in ophthalmology. Although synthetic cannabinoids combined with modulation of the endocannabinoid system might become the future of ophthalmology, more studies on this topic should be conducted.
Share
without publication fees
without publication fees